Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Autonomic dysfunction following traumatic brain injury: translational insights.

Khalid F, Yang GL, McGuire JL, Robson MJ, Foreman B, Ngwenya LB, Lorenz JN.

Neurosurg Focus. 2019 Nov 1;47(5):E8. doi: 10.3171/2019.8.FOCUS19517.

PMID:
31675718
2.

Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities.

Liu X, Nemeth DP, McKim DB, Zhu L, DiSabato DJ, Berdysz O, Gorantla G, Oliver B, Witcher KG, Wang Y, Negray CE, Vegesna RS, Sheridan JF, Godbout JP, Robson MJ, Blakely RD, Popovich PG, Bilbo SD, Quan N.

Immunity. 2019 Mar 19;50(3):764-766. doi: 10.1016/j.immuni.2019.02.012. No abstract available.

PMID:
30893590
3.

Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities.

Liu X, Nemeth DP, McKim DB, Zhu L, DiSabato DJ, Berdysz O, Gorantla G, Oliver B, Witcher KG, Wang Y, Negray CE, Vegesna RS, Sheridan JF, Godbout JP, Robson MJ, Blakely RD, Popovich PG, Bilbo SD, Quan N.

Immunity. 2019 Feb 19;50(2):317-333.e6. doi: 10.1016/j.immuni.2018.12.012. Epub 2019 Jan 22. Erratum in: Immunity. 2019 Mar 19;50(3):764-766.

PMID:
30683620
4.

Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences.

Quinlan MA, Krout D, Katamish RM, Robson MJ, Nettesheim C, Gresch PJ, Mash DC, Henry LK, Blakely RD.

ACS Chem Neurosci. 2019 Jul 17;10(7):3249-3260. doi: 10.1021/acschemneuro.8b00689. Epub 2019 Feb 5.

PMID:
30668912
5.

p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse.

Robson MJ, Quinlan MA, Margolis KG, Gajewski-Kurdziel PA, Veenstra-VanderWeele J, Gershon MD, Watterson DM, Blakely RD.

Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10245-E10254. doi: 10.1073/pnas.1809137115. Epub 2018 Oct 8.

6.

Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation.

Burke SJ, Batdorf HM, Burk DH, Martin TM, Mendoza T, Stadler K, Alami W, Karlstad MD, Robson MJ, Blakely RD, Mynatt RL, Collier JJ.

Mol Metab. 2018 Aug;14:95-107. doi: 10.1016/j.molmet.2018.06.003. Epub 2018 Jun 6.

7.

Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery.

Robson MJ, Quinlan MA, Blakely RD.

ACS Chem Neurosci. 2017 May 17;8(5):932-942. doi: 10.1021/acschemneuro.6b00412. Epub 2017 Apr 3. Review.

PMID:
28345868
8.

Alzheimer's disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities.

Turner RC, Lucke-Wold BP, Robson MJ, Lee JM, Bailes JE.

Brain Inj. 2016;30(11):1279-1292. doi: 10.1080/02699052.2016.1193631. Epub 2016 Aug 11. Review.

9.

Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1.

Robson MJ, Zhu CB, Quinlan MA, Botschner DA, Baganz NL, Lindler KM, Thome JG, Hewlett WA, Blakely RD.

PLoS One. 2016 Mar 1;11(3):e0150068. doi: 10.1371/journal.pone.0150068. eCollection 2016.

10.

Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery.

Turner RC, Lucke-Wold BP, Logsdon AF, Robson MJ, Lee JM, Bailes JE, Dashnaw ML, Huber JD, Petraglia AL, Rosen CL.

Front Neurol. 2015 Oct 26;6:223. doi: 10.3389/fneur.2015.00223. eCollection 2015. Review.

11.

The Quest to Model Chronic Traumatic Encephalopathy: A Multiple Model and Injury Paradigm Experience.

Turner RC, Lucke-Wold BP, Logsdon AF, Robson MJ, Dashnaw ML, Huang JH, Smith KE, Huber JD, Rosen CL, Petraglia AL.

Front Neurol. 2015 Oct 20;6:222. doi: 10.3389/fneur.2015.00222. eCollection 2015.

12.

A requirement of serotonergic p38α mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors.

Baganz NL, Lindler KM, Zhu CB, Smith JT, Robson MJ, Iwamoto H, Deneris ES, Hewlett WA, Blakely RD.

Transl Psychiatry. 2015 Nov 3;5:e671. doi: 10.1038/tp.2015.168.

13.

Amelioration of nicotinamide adenine dinucleotide phosphate-oxidase mediated stress reduces cell death after blast-induced traumatic brain injury.

Lucke-Wold BP, Naser ZJ, Logsdon AF, Turner RC, Smith KE, Robson MJ, Bailes JE, Lee JM, Rosen CL, Huber JD.

Transl Res. 2015 Dec;166(6):509-528.e1. doi: 10.1016/j.trsl.2015.08.005. Epub 2015 Sep 8.

PMID:
26414010
14.

Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy.

Lucke-Wold BP, Turner RC, Logsdon AF, Nguyen L, Bailes JE, Lee JM, Robson MJ, Omalu BI, Huber JD, Rosen CL.

J Neurosurg. 2016 Mar;124(3):687-702. doi: 10.3171/2015.3.JNS141802. Epub 2015 Sep 18.

PMID:
26381255
15.

Platelet response to increased aspirin dose in patients with persistent platelet aggregation while treated with aspirin 81 mg.

Gengo F, Westphal ES, Rainka MM, Janda M, Robson MJ, Hourihane JM, Bates V.

J Clin Pharmacol. 2016 Apr;56(4):414-21. doi: 10.1002/jcph.608. Epub 2015 Oct 26.

PMID:
26239393
16.

Role of sigma-1 receptors in neurodegenerative diseases.

Nguyen L, Lucke-Wold BP, Mookerjee SA, Cavendish JZ, Robson MJ, Scandinaro AL, Matsumoto RR.

J Pharmacol Sci. 2015 Jan;127(1):17-29. doi: 10.1016/j.jphs.2014.12.005. Epub 2014 Dec 11. Review.

17.

Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms.

Logsdon AF, Turner RC, Lucke-Wold BP, Robson MJ, Naser ZJ, Smith KE, Matsumoto RR, Huber JD, Rosen CL.

Front Cell Neurosci. 2014 Dec 10;8:421. doi: 10.3389/fncel.2014.00421. eCollection 2014.

18.

Sigma receptors as potential therapeutic targets for neuroprotection.

Nguyen L, Kaushal N, Robson MJ, Matsumoto RR.

Eur J Pharmacol. 2014 Nov 15;743:42-7. doi: 10.1016/j.ejphar.2014.09.022. Epub 2014 Sep 27. Review.

19.

Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia.

Matsumoto RR, Seminerio MJ, Turner RC, Robson MJ, Nguyen L, Miller DB, O'Callaghan JP.

Pharmacol Ther. 2014 Oct;144(1):28-40. doi: 10.1016/j.pharmthera.2014.05.001. Epub 2014 May 14. Review.

20.

The Pseudomonas aeruginosa exoenzyme Y impairs endothelial cell proliferation and vascular repair following lung injury.

Stevens TC, Ochoa CD, Morrow KA, Robson MJ, Prasain N, Zhou C, Alvarez DF, Frank DW, Balczon R, Stevens T.

Am J Physiol Lung Cell Mol Physiol. 2014 May 15;306(10):L915-24. doi: 10.1152/ajplung.00135.2013. Epub 2014 Apr 4.

21.

Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan.

Nguyen L, Robson MJ, Healy JR, Scandinaro AL, Matsumoto RR.

PLoS One. 2014 Feb 28;9(2):e89985. doi: 10.1371/journal.pone.0089985. eCollection 2014.

22.

SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.

Robson MJ, Turner RC, Naser ZJ, McCurdy CR, O'Callaghan JP, Huber JD, Matsumoto RR.

Exp Neurol. 2014 Apr;254:180-9. doi: 10.1016/j.expneurol.2014.01.020. Epub 2014 Feb 6.

23.

Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects.

Matsumoto RR, Nguyen L, Kaushal N, Robson MJ.

Adv Pharmacol. 2014;69:323-86. doi: 10.1016/B978-0-12-420118-7.00009-3. Review.

PMID:
24484982
24.

Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.

Kaushal N, Robson MJ, Rosen A, McCurdy CR, Matsumoto RR.

Eur J Pharmacol. 2014 Feb 5;724:193-203. doi: 10.1016/j.ejphar.2013.12.039. Epub 2013 Dec 28.

25.

Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats.

Turner RC, Naser ZJ, Logsdon AF, DiPasquale KH, Jackson GJ, Robson MJ, Gettens RT, Matsumoto RR, Huber JD, Rosen CL.

Exp Neurol. 2013 Oct;248:520-9. doi: 10.1016/j.expneurol.2013.07.008. Epub 2013 Jul 20.

PMID:
23876514
26.

σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation.

Robson MJ, Seminerio MJ, McCurdy CR, Coop A, Matsumoto RR.

Pharmacol Rep. 2013;65(2):343-9.

27.

SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation.

Robson MJ, Turner RC, Naser ZJ, McCurdy CR, Huber JD, Matsumoto RR.

Exp Neurol. 2013 Sep;247:134-42. doi: 10.1016/j.expneurol.2013.04.009. Epub 2013 Apr 28.

28.

Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment?

Turner RC, Lucke-Wold BP, Robson MJ, Omalu BI, Petraglia AL, Bailes JE.

Front Neurol. 2013 Jan 17;3:186. doi: 10.3389/fneur.2012.00186. eCollection 2012.

29.

Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.

Kaushal N, Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR.

Eur Neuropsychopharmacol. 2013 Aug;23(8):960-71. doi: 10.1016/j.euroneuro.2012.08.005. Epub 2012 Aug 24.

30.

Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus.

Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR.

Eur J Pharmacol. 2012 Sep 15;691(1-3):103-9. doi: 10.1016/j.ejphar.2012.07.029. Epub 2012 Jul 20.

31.

Sigma-1 receptors: potential targets for the treatment of substance abuse.

Robson MJ, Noorbakhsh B, Seminerio MJ, Matsumoto RR.

Curr Pharm Des. 2012;18(7):902-19. Review.

PMID:
22288407
32.

CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain.

Xu YT, Robson MJ, Szeszel-Fedorowicz W, Patel D, Rooney R, McCurdy CR, Matsumoto RR.

Pharmacol Biochem Behav. 2012 Mar;101(1):174-80. doi: 10.1016/j.pbb.2011.12.016. Epub 2011 Dec 30.

33.

Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.

Seminerio MJ, Robson MJ, Abdelazeem AH, Mesangeau C, Jamalapuram S, Avery BA, McCurdy CR, Matsumoto RR.

AAPS J. 2012 Mar;14(1):43-51. doi: 10.1208/s12248-011-9311-8. Epub 2011 Dec 20.

34.

AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells.

Kaushal N, Elliott M, Robson MJ, Iyer AK, Rojanasakul Y, Coop A, Matsumoto RR.

Mol Pharmacol. 2012 Mar;81(3):299-308. doi: 10.1124/mol.111.074120. Epub 2011 Nov 18.

35.

Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo.

Robson MJ, Elliott M, Seminerio MJ, Matsumoto RR.

Eur Neuropsychopharmacol. 2012 Apr;22(4):308-17. doi: 10.1016/j.euroneuro.2011.08.002. Epub 2011 Sep 10.

PMID:
21911285
36.

Synthesis and pharmacological evaluation of indole-based sigma receptor ligands.

Mésangeau C, Amata E, Alsharif W, Seminerio MJ, Robson MJ, Matsumoto RR, Poupaert JH, McCurdy CR.

Eur J Med Chem. 2011 Oct;46(10):5154-61. doi: 10.1016/j.ejmech.2011.08.031. Epub 2011 Aug 29.

37.

Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents.

Kaushal N, Robson MJ, Vinnakota H, Narayanan S, Avery BA, McCurdy CR, Matsumoto RR.

AAPS J. 2011 Sep;13(3):336-46. doi: 10.1208/s12248-011-9274-9. Epub 2011 Apr 15.

38.

Sigma receptors: potential targets for a new class of antidepressant drug.

Fishback JA, Robson MJ, Xu YT, Matsumoto RR.

Pharmacol Ther. 2010 Sep;127(3):271-82. doi: 10.1016/j.pharmthera.2010.04.003. Epub 2010 May 11. Review.

39.

Another example of regression to the mean (not).

Alston RP, Deary IJ, Robson MJ, Andrews PJ, Souter MJ.

Anesth Analg. 2002 Dec;95(6):1823. No abstract available.

PMID:
12456475
40.

Neuropsychological performance and noradrenaline function in chronic fatigue syndrome under conditions of high arousal.

Morriss RK, Robson MJ, Deakin JF.

Psychopharmacology (Berl). 2002 Sep;163(2):166-73. Epub 2002 Jul 30.

PMID:
12202963
41.

Apolipoprotein E and neurocognitive outcome from coronary artery surgery.

Robson MJ, Alston RP, Andrews PJ, Wenham PR, Souter MJ, Deary IJ.

J Neurol Neurosurg Psychiatry. 2002 May;72(5):675-6. No abstract available.

42.

Jugular bulb oxyhemoglobin desaturation, S100beta, and neurologic and cognitive outcomes after coronary artery surgery.

Robson MJ, Alston RP, Deary IJ, Andrews PJ, Souter MJ.

Anesth Analg. 2001 Oct;93(4):839-45.

PMID:
11574343
43.

Pigmented villonodular synovitis of lumbar facet joint: a rare cause of nerve root entrapment.

Sampathkumar K, Rajasekhar C, Robson MJ.

Spine (Phila Pa 1976). 2001 May 15;26(10):E213-5.

PMID:
11413441
44.

Cognition after coronary artery surgery is not related to postoperative jugular bulb oxyhemoglobin desaturation.

Robson MJ, Alston RP, Deary IJ, Andrews PJ, Souter MJ, Yates S.

Anesth Analg. 2000 Dec;91(6):1317-26.

PMID:
11093972
45.

Anaesthesia, jugular venous oxyhaemoglobin saturation and coronary artery bypass surgery.

Alston RP, Robson MJ, Andrews PJ, Millar SA, Souter MJ.

Br J Anaesth. 2000 Oct;85(4):664. No abstract available.

PMID:
11064638
46.

Time course of neurone-specific enolase and S-100 protein release during and after coronary artery bypass grafting.

Robson MJ, Alston RP.

Br J Anaesth. 1999 Sep;83(3):531; author reply 532. No abstract available.

PMID:
10896405
47.

A prospective evaluation of both outcome and psychological status in 100 patients with mechanical lower back pain.

Harris NJ, Robson MJ, Simpson S, Mehta BH.

J Back Musculoskelet Rehabil. 1997 Jan 1;9(1):39-41. doi: 10.3233/BMR-1997-9112. No abstract available.

PMID:
24572949
48.

Hydroxyapatite-coated hip prostheses: difficulties with revision in 4 cases.

Bhamra MS, Rao GS, Robson MJ.

Acta Orthop Scand. 1996 Feb;67(1):49-52.

PMID:
8615102
49.

Ultrasound guided aspiration of symptomatic supraspinatus calcific deposits.

Bradley M, Bhamra MS, Robson MJ.

Br J Radiol. 1995 Jul;68(811):716-9.

PMID:
7640925
50.

Physiological integration in the clonal perennial herb Trifolium repens L.

Chapman DF, Robson MJ, Snaydon RW.

Oecologia. 1992 Mar;89(3):338-347. doi: 10.1007/BF00317411.

PMID:
28313082

Supplemental Content

Loading ...
Support Center